BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma-Reference-Cited by-同舟云学术

BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma

Published:2016-02 Issue:1 Volume:26 Page:83-87
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Sloot Sarah,Zager Jonathan S.,Kudchadkar Ragini R.,Messina Jane L.,Benedict Jacob J.,Gonzalez Ricardo J.,DeConti Ronald,Turner Leslie M.,McCardle Timothy,Smalley Keiran S.M.,Weber Jeffrey S.,Sondak Vernon K.,Gibney Geoffrey T.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference21 articles.

1. Cancer statistics, 2015.;Siegel;CA Cancer J Clin,2015

2. . MSLT Group. Final trial report of sentinel-node biopsy versus nodal observation in melanoma.;Morton;N Engl J Med,2014

3. . MSLT Group. Sentinel-node biopsy or nodal observation in melanoma.;Morton;N Engl J Med,2006

4. Analysis of prognosis and disease progression after local recurrence of melanoma.;Dong;Cancer,2000

5. Time course and pattern of metastasis of cutaneous melanoma differ between men and women.;Mervic;PloS One,2012

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges;Cancers;2022-08-27

2. Adjuvant and Neoadjuvant Therapies in Cutaneous Melanoma;Oral and Maxillofacial Surgery Clinics of North America;2022-05

3. 18F-FDG PET/CT During Neoadjuvant Targeted Therapy in Prior Unresectable Stage III Melanoma Patients;Clinical Nuclear Medicine;2022-04-22

4. Neoadjuvant immunotherapy is reshaping cancer management across multiple tumour types: The future is now!;European Journal of Cancer;2021-07

5. Evolution of Neoadjuvant Therapy in Melanoma;Melanoma in Clinical Practice;2021